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Severe mental illnesses (SMI), including major depressive disorder, bipolar disorder, and 
schizophrenia, are associated with increased inflammation. Given diet’s role in modulating 
inflammatory processes, excessive calorie-dense, nutrient-deficient processed food 
intake may contribute toward the heightened inflammation observed in SMI. This review 
assesses the evidence from observational and experimental studies to investigate how 
diet may affect physical and mental health outcomes in SMI through inflammation-
related pathways. Cross-sectional studies indicate that individuals with SMI, particularly 
schizophrenia, consume more pro-inflammatory foods and fewer anti-inflammatory 
nutrients than the general population. Cohort studies indicate that high levels of dietary 
inflammation are associated with increased risk of developing depression, but there is 
currently a lack of evidence for schizophrenia or bipolar disorder. Randomized controlled 
trials show that dietary interventions improve symptoms of depression, but none have 
tested the extent to which these benefits are due to changes in inflammation. This review 
summarizes evidence on dietary inflammation in SMI, explores the directionality of these 
links, and discusses the potential use of targeted nutritional interventions for improving 
psychological well-being and physical health outcomes in SMI. Establishing the extent to 
which diet explains elevated levels of inflammatory markers observed in SMI is a priority 
for future research.
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INTRODUCTION AND AIMS
Recent meta-analyses have confirmed that severe mental 
illnesses (SMI), including major depressive disorder (MDD), 
bipolar disorder, and schizophrenia, are associated with increased 
levels of both peripheral inflammatory markers (1) and systemic 
inflammation (2). Additionally, heightened inflammation could 
present a novel treatment target for MDD, given that the anti-
depressant efficacy of various pharmacological and lifestyle 
interventions appears to be associated with reductions in 
inflammation (3, 4). In schizophrenia, the evidence for 
antipsychotics altering inflammatory markers is mixed (1, 5), 
although there is some preliminary evidence to indicate that 
various adjunctive interventions may confer beneficial effects 
through reducing inflammatory status (6, 7).
Calorie-dense diets that are high in saturated fats and simple 
carbohydrates appear to increase peripheral inflammatory markers, 
whereas diets high in fiber and vegetables reduce inflammation 
(8–12). Systematic reviews of dietary patterns in people with 
SMI have shown elevated intakes of sugar-sweetened soft drinks, 
refined grains, and processed meat are common in this population 
(13, 14). However, the degree to which these dietary patterns 
heighten inflammation in SMI, and the potential impact on 
physical and mental health outcomes, is relatively unexplored. This 
comprehensive review brings together the evidence from cross-
sectional, longitudinal, and experimental studies on this topic to:
 (i) Examine the extent to which inflammatory potential of 
the diet (hereafter referred to as “dietary inflammation”) is 
elevated in SMI populations;
 (ii) Explore the directionality of the links between dietary 
inflammation and symptoms of SMI;
 (iii) Discuss the existing evidence for the use of nutritional 
interventions for improving health outcomes in SMI and 
how these effects may act through inflammatory pathways.
FOOD INTAKE AND DIETARY 
INFLAMMATION IN PEOPLE WITH 
SEVERE MENTAL ILLNESSES
A recent large-scale study of the UK Biobank (15) compared the 
macro- and micro-nutrient intake of individuals with diagnosed 
MDD (n = 14,619), bipolar disorder (n = 952), and schizophrenia 
(n = 262) to healthy controls (n = 54,010), showing that people 
with SMI consumed significantly more carbohydrate, sugar, fat, 
and saturated fat than healthy controls (all p < 0.001), even when 
controlling for age, gender, education, BMI, social deprivation, 
and ethnicity. The study also examined the inflammatory 
potential of food intakes of individuals with SMI compared with 
the general population using the “Dietary Inflammatory Index” 
(DII®). The DII is a literature-derived, population-based measure, 
which provides an estimate of the inflammatory potential of an 
individual’s diet from up to 45 individual food parameters (16). 
DII scores have been validated against various blood markers of 
inflammatory status across a number of different populations 
(17–21). The DII scores in SMI samples in the UK Biobank are 
displayed in Figure 1 [derived from Firth et al. (15)], adjusted 
for age, gender, and total energy intake. These data show highly 
elevated dietary inflammation in individuals with schizophrenia, 
along with smaller, but significantly increased, levels of dietary 
inflammation in individuals with MDD (all p < 0.01). Although 
dietary inflammation in the bipolar disorder group was similarly 
FIGURE 1 | Dietary Inflammatory Index (DII) scores from 53,270 healthy controls, compared to major depressive disorder (MDD) (n = 14,422), bipolar disorders 
(BPD, n = 933), and schizophrenia (SZ, n = 254). Midpoint shows adjusted means. Error bars show 95% confidence intervals. *Statistically significant difference 
compared to healthy controls. Data derived from Firth et al. (15).
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larger than healthy controls (p = 0.03), this difference was 
reduced to a marginally non-significant trend after adjusting for 
BMI and socioeconomic status (p = 0.07).
It is interesting to note that despite the vast number of studies 
examining elevated levels of peripheral inflammation observed 
across all classes of SMI (1), none have accurately controlled for the 
potential confounding factor of diet. Furthermore, a priority for 
future research is to validate the accuracy of dietary reporting in SMI. 
Interestingly, previous research comparing other lifestyle factors 
(i.e., physical activity) using objective against self-report measures 
in SMI have shown that people with schizophrenia significantly 
overestimate health behaviors compared with the general population 
(22). Therefore, replication of these findings, using validated 
measures in SMI alongside blood markers of inflammation, is 
required to establish how diet may relate to inflammation in SMI.
Along with poor mental health, people with SMI experience 
drastic inequalities in physical health, including elevated rates 
of obesity, diabetes, and cardiometabolic disorders, ultimately 
contributing to a reduced life expectancy of around 20 years 
(23). Given the clear causal links between dietary inflammation 
and these health outcomes established in the general population 
(10–12), and the established benefits of dietary interventions for 
physical health in SMI (24), it is reasonable to explore dietary 
inflammation as one risk factor driving some of the physical health 
inequalities observed in this population. Indeed, the highest levels 
of dietary inflammation are observed in schizophrenia: a group that 
also experiences significantly worse physical health outcomes than 
other classes of SMI (25, 26). Poor dietary quality associated with 
schizophrenia may even be driven by side effects of antipsychotic 
medications, which may increase appetite through interfering with 
the “hunger hormone,” ghrelin (27). Clearly, there is an urgent need 
for future research to determine the mechanisms through which 
poor diet may be driving adverse health outcomes in people with 
SMI. This line of investigation will provide novel insights into 
the etiology of the physical health inequalities observed in this 
population and has the potential to inform clinical care.
A key limitation of the current literature is a lack of large-scale 
data on dietary patterns among young people with SMI, thus 
making it difficult to determine whether poor diet precedes the 
onset of mental illness, or vice versa. In the general population, data 
suggest that younger people tend to have worse diets than older 
adults (28). This also may apply to SMI populations, as nutritional 
deficits in psychosis are evident even prior to antipsychotic 
treatment (29). Thus, in the following section, we review the 
prospective studies examining links between high levels of dietary 
inflammation and the subsequent onset of mental illness.
PROSPECTIVE ASSOCIATIONS 
BETWEEN DIETARY INFLAMMATION 
AND PSYCHIATRIC SYMPTOMS
Poor nutrition has been implicated in the onset and persistence of 
psychiatric disorders (30). In general, cohort studies have shown 
that dietary patterns, such as a Mediterranean diet, which is rich 
in fruits, vegetables, olive oil, and legumes, may be protective 
against mental health disorders (31–38). By contrast, increased 
risk of mental disorders has been observed with dietary patterns, 
such as the Western diet, characterized by high intake of saturated 
fat and refined carbohydrates (33, 39–41).
Inflammation presents one feasible mechanism through 
which diet may affect the risk of mental disorders. This is 
supported by multiple cohort studies showing that higher DII 
scores are associated with increased risk of depression (42–49). 
Combining all longitudinal data on this topic (including 77,420 
participants from seven different studies), a recent meta-analysis 
confirmed that higher levels of dietary inflammation were 
associated with 31% increased risk of depression over the 5- to 
13-year follow-up period (50). This meta-analysis also found 
that pro-inflammatory diets were more strongly associated with 
depression among females than males (50), although significant 
relationships were observed for both sexes.
Despite these positive findings on links between depression 
and dietary inflammation calculated from self-report measures, 
future research must establish if these relationships are mediated 
by biological markers of inflammatory status. Although a 
number of studies have found joint relationships between 
dietary inflammation, inflammatory markers, and depressive 
symptoms (51–53), those findings are inconsistent with other 
results showing that dietary patterns associated with heightened 
inflammatory markers do not consistently predict depression 
scores (54).
Currently, there is an urgent need for longitudinal studies to 
assess how dietary inflammation is related to the onset of other 
classes of SMI, because there is currently no strong evidence 
linking dietary inflammation with risk of bipolar disorder or 
schizophrenia. As the effects of dietary inflammation on mental 
health are also observed in adolescence (51), when the majority 
of SMIs first arise (55), the potential impact that this may have 
on risk of bipolar and psychotic disorders is worthy of further 
examination.
Along with clinical symptoms, people with SMI (and 
particularly schizophrenia) also display a range of cognitive 
deficits (56–58), which impede daily functioning (59, 60), and 
are not treated by psychotropic medications (61, 62). There 
is an emerging literature suggesting that elevated peripheral 
inflammatory markers are associated with deficits in cognitive 
function among patients with psychiatric disorders (1, 63). 
Though the specific mechanisms underlying this association 
remain unclear, chronic and acute inflammation is thought to 
have a number of detrimental effects on brain structure and 
function, which, in turn, appear to adversely affect cognitive 
performance (64–66).
Poor diet and obesity also have a well-established link with 
cognitive dysfunction (67, 68). There is mounting evidence 
that these associations may be mediated by inflammatory 
processes (69), suggesting that diet has the potential to act as a 
modifiable risk factor for cognitive dysfunction both in clinical 
and non-clinical populations. Much of the work investigating 
the association between diet, inflammation, and cognition has 
come from a series of cross-sectional and longitudinal studies in 
older adults, which indicate that diets with high inflammatory 
potential may be associated with accelerated cognitive decline 
and reduced brain volume (70–72). Considering the high levels 
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of dietary inflammation and cognitive deficits observed in SMI, 
along with indicated relationships between cognitive functioning 
and diet in other populations, this area presents a promising 
avenue for future research (73).
EXPERIMENTAL MANIPULATION OF 
DIETARY INFLAMMATION: CAN WE MAKE 
A DIFFERENCE TO MENTAL HEALTH?
A recent meta-analysis examined the effects of dietary 
interventions on mental health in 16 randomized controlled 
trials (RCTs) of 45,826 participants (74). Dietary improvement 
significantly reduced symptoms of depression [g = 0.275; 95% 
confidence interval (CI), 0.10–0.45; p = 0.002], with no changes 
in anxiety observed. Interestingly, similar degrees of benefit for 
depressive symptoms were observed from all the different dietary 
approaches trialed; dietary interventions primarily designed 
to improve nutrition [e.g., the Mediterranean diet, which is 
typically linked with anti-inflammatory effects (11)] were no 
more beneficial for mental health than those aimed at reducing 
bodyweight or decreasing dietary fat intake (74). This may be 
because, even without increasing anti-inflammatory nutrient 
intake, weight-loss and changes in energy balance can reduce 
inflammation through reducing excess adipose tissue, which is 
associated with heightened inflammation (75, 76).
However, 15 of the 16 RCTs in this meta-analysis only 
examined effects on depressive symptoms in samples with “sub-
clinical” depression (i.e., samples without a confirmed diagnosis of 
MDD). However, the single trial conducted in clinically depressed 
participants (75) observed large reductions in depressive 
symptoms from a 12-week modified Mediterranean diet, with 
32.3% of participants achieving remission from the dietary 
intervention versus 8.0% in the social support control condition 
(p = 0.028). Subsequent RCTs have replicated these findings of the 
Mediterranean diet reducing symptoms in people with moderate 
to severe depression (76). As a meta-analysis of 50 studies (10) has 
shown, the Mediterranean diet significantly reduces inflammatory 
markers in other (i.e., non-psychiatric) populations, and it is 
possible that the benefits in people with depression are linked 
to the anti-inflammatory effects. However, this has yet to be 
assessed, as no studies have measured changes in inflammation 
following dietary interventions in depression. Furthermore, there 
is currently no experimental evidence showing beneficial effects 
of dietary interventions on inflammation and mental health in 
schizophrenia or bipolar disorder.
Nonetheless, RCTs of individual nutrient-based supplements 
(nutraceuticals) have provided valuable insights into how nutrition 
can influence mental health in SMI through inflammatory 
pathways. For instance, in an RCT of 155 individuals with MDD, 
Rapaport et al. (77) found that patients with baseline elevated 
markers of inflammation were significantly more responsive to 
omega-3 treatment (mediated, in principle, via eicosapentenoic 
acid) (78). The antidepressant effects of omega-3 fatty acids 
working through the reduction of inflammation also were 
implicated in a seminal study by Su (79). This study examined 
depression in people with hepatitis C, undergoing interferon 
(IFN) alpha therapy, which commonly induces depressive 
symptoms due to its inflammatory effects (80). However, Su 
et al. (79) found that omega-3 supplementation reduced the 
risk of developing depression following INF-a treatment. 
Other nutrients, such as folate, have also been found to reduce 
depression in people with high levels of inflammation (81), again 
indicating these adjunctive treatments may confer symptomatic 
benefits through inflammatory pathways.
Beyond MDD, there are preliminary data from RCTs 
suggesting that anti-inflammatory nutrients, such as omega-3 
and folate-based compounds, may also be effective for other 
SMIs, including bipolar disorder and schizophrenia (82). Because 
inflammation is particularly elevated during onset of psychotic 
disorders, these adjunctive treatments may have neuroprotective 
effects in the early stages of illness among young people (83, 84), 
potentially improving cognitive outcomes for some patients. 
However, the extent to which their effects are due specifically to 
their anti-inflammatory properties is not fully ascertained.
CONCLUSIONS AND FUTURE RESEARCH
The current evidence from human studies examining the role 
of dietary inflammation in SMI are shown in Figure 2. The 
cross-sectional literature provides consistent evidence that 
individuals with SMI consume more pro-inflammatory foods 
than the general population, and fewer anti-inflammatory 
nutrients—which may contribute toward the heightened levels 
of inflammatory markers observed in SMI. In the few studies 
that have compared different classes of SMI, the highest dietary 
risks are observed among people with schizophrenia (who also 
have the most severe disparities in physical health, compared 
with other mental disorders). However, the bulk of both the 
observational and experimental studies examining the links 
between dietary inflammation and mental health have been 
conducted in depression (see Figure 2A)—with a relative 
dearth of evidence in other disorders. Therefore, there is now 
a need for researchers and clinicians to build upon the existing 
evidence in MDD and give further attention to the impact of 
dietary inflammation in schizophrenia and bipolar disorder 
and explore the potential benefits of dietary modification for 
these populations.
The longitudinal studies now provide population-scale data 
showing that high levels of dietary inflammation are associated 
with increased the likelihood of developing depression over 
time. However, there is little evidence to suggest that this also 
applies to schizophrenia or bipolar disorder. Alongside this, a key 
remaining question in this field (which can only be addressed 
by experimental studies), is: “Can reducing dietary inflammation 
make a difference?” or, more specifically, “Is it possible that 
dietary modification can reduce inflammation and thus improve 
symptoms in people with SMI?”
Currently, there is no experimental evidence to show that 
a specific “anti-inflammatory” diet influences psychiatric 
symptoms of schizophrenia or bipolar disorder. Furthermore, 
whereas RCTs and meta-analyses have recently shown that 
dietary improvement reduces symptoms of depression (in both 
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FIGURE 2 | Key Findings and Future Questions: A map of the evidence for the role of dietary inflammation in severe mental illnesses (SMI), with regard to (A) 
different conditions, and (B) different aspects of the interaction between dietary inflammation, inflammatory markers, and psychiatric disorders.
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clinical and non-clinical populations), the extent to which this 
is due to anti-inflammatory effects of dietary interventions 
has not been assessed. Nonetheless, some evidence from 
nutraceutical trials suggests that certain anti-inflammatory 
nutrients may provide adjunctive treatments for subgroups of 
individuals with mental health conditions with particularly 
elevated levels of inflammation.
With regard to whole-diet interventions, it is interesting to 
consider the prevalent finding that the weight loss, fat reduction, 
or Mediterranean diets trialed so far all appear to confer similar 
beneficial effects on depressive symptoms. Whereas this may 
indicate a lack of specificity, it should be acknowledged that 
each of these interventions, although differing in stated aims, 
generally have some key factors in common. Specifically, all of 
these interventions generally involve decreasing the amount of 
refined, processed calorie-dense foods, while increasing intake 
of nutrient-dense natural-occurring fiber and vegetables. 
Therefore, the general equivalence across difference types 
of diets could ultimately produce an encouraging message, 
suggesting that highly specific or specialized diets are perhaps 
unnecessary for the average individuals, as adhering to very 
simple and universally accepted dietary advice appears to be 
equally beneficial for psychological well-being—and sufficient 
for avoiding the potentially deleterious effects on mental health 
of a “junk food” diet. To provide greater insight on this, future 
research should attempt to elucidate the specific mechanisms 
through which the dietary impacts upon inflammation to 
influence mental health. For instance, hyperglycemia and 
hyperinsulinemia after a meal of refined starches and sugars 
may promote inflammation by increasing production of free 
radicals and pro inflammatory cytokines (85, 86), whereas 
high levels of saturated fat intake decrease production of 
short chain fatty acids such as butyrate, which have anti-
inflammatory properties (87). Alongside these nutritional 
factors, obesity and excess adipose tissue themselves directly 
heighten inflammation—suggesting that attenuating these 
adverse states of health through calorie restriction and low-
fat diets could reduce inflammatory status and thus improve 
psychological well-being (74, 88). Along with reducing dietary 
patterns with inflammatory potential, the adequate intake 
of beneficial nutrients is another mechanism through which 
“healthy diets” improve inflammatory profiles and support 
mental health. For example, various vitamins and minerals 
have been shown to modulate the “kyrenuine pathway” 
(89),  which regulates the immune system, particularly with 
regard neurotrophic factor production, NMDA receptor 
signaling, and glutamatergic neurotransmission—all of which 
are implicated in inflammatory hypotheses of SMI (90).
A further emerging pathway through which inflammatory 
potential of the diet may induce depressive symptoms is 
by interacting with the gut–brain axis and affecting the gut 
microbiome (91). However, the role of individual nutrients on 
modifying the microbiome is still poorly understood, as are the 
exact mechanisms by which the gut microbiome itself affects 
mental health (92).
Further investment in human trials is now required to 
establish the feasibility and efficacy of dietary improvement as 
an intervention for improving physical and mental health across 
different classes of SMI. Additionally, future trials should aim to 
measure peripheral and central inflammation before and after 
dietary interventions in SMI. In this way, researchers could apply 
subgroup and mediation analyses to examine how the potential 
benefits of nutrition interventions are related to changes in 
inflammatory status. Ultimately, this line of investigation could 
shed new light on the interface between physical and mental health 
in people with SMI, along with presenting novel interventions 
and adjunctive treatments for improving psychological well-
being and tackling the poor cardiometabolic health observed in 
this underserved population.
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